Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PEARLS: Rosiglitazone for In-Stent Restenosis
NCT00465296Phase 3Terminated
- Sponsor
- MedStar Health Research Institute
- Start
- Jan 2006
- Primary completion
- Jul 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of rosiglitazone in in-stent restenosis (ISR), sponsored by MedStar Health Research Institute. Started Jan 2006; status: terminated.
02
Drugs
rosiglitazone
03
Conditions
in-stent restenosis (ISR)
Beyond the preview
Go deeper on NCT00465296.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00465296.